BackStatera BioPharma Overview

Statera BioPharma Common Stock

Track Statera BioPharma's common stock ($250K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$253724.00
↓ 99.06% YoYΔ $-26.78M vs prior year quarter

Peer trimmed avg / median

Loading

Statera BioPharma Common Stock History

Loading

Statera BioPharma vs. peers: Common Stock Comparison

Loading

Statera BioPharma Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Statera BioPharma (STAB) FAQ

As of the most recent data (September 2022), STAB shows a common stock of $250K. That compares with $27M in the prior-year period — down 99.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, STAB's common stock is now $250K (was $27M) — a 99.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Statera BioPharma is outperforming or lagging.

Tracking STAB's common stock over time shows whether Statera BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $250K That compares with $27M in the prior-year period — down 99.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Statera BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $250K) with ownership activity and broader fundamentals.

Statera BioPharma's common stock is $250K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.